• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anaphylactic Shock (1703); Hemorrhage/Bleeding (1888); Mitral Regurgitation (1964); Renal Failure (2041); Heart Failure (2206); Respiratory Failure (2484)
Event Date 05/31/2020
Event Type  Injury  
Manufacturer Narrative
Date of event: dates are estimated.The devices were not returned for analysis and a review of the lot history record and similar complaint review could not be performed as the part and lot information regarding the complaint devices was not provided.Based on the information provided a conclusive cause for the reported anaphylactic shock, respiratory failure, hemorrhage, recurrent mitral regurgitation, heart failure, and renal failure cannot be determined.The reported patient effect of anaphylactic shock, respiratory failure, hemorrhage, recurrent mitral regurgitation, heart failure, and renal failure, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.There is no indication of a product issue with respect to manufacture, design, or labeling.Attachment: article titled, outcomes of urgent/emergent transcatheter mitral valve repair (mitraclip): a single center experience.
 
Event Description
This is filed to report shock, respiratory failure, bleeding, recurrent mitral regurgitation (mr), heart failure and kidney failure.It was reported through a research article that from january 2018 to march 2019, 20 patient patients underwent urgent/emergent transcatheter mitral valve repair with a mitraclip.Over the 14-month period, the mitraclip may have contributed to shock, respiratory failure, bleeding, recurrent mitral regurgitation (mr), heart failure, kidney failure, hospitalization, medical intervention and surgical intervention.Details are listed in the attached article, titled ¿outcomes of urgent/emergent transcatheter mitral valve repair (mitraclip): a single center experience.¿ no additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key10351165
MDR Text Key202073900
Report Number2024168-2020-06367
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 07/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/07/2020
Initial Date FDA Received07/31/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age72 YR
-
-